Chemoinformaics analysis of 4-Hydroxy-trans-cinnamic acid 3-(3-methoxy-4-hydroxyphenyl)propyl ester
| Molecular Weight | 328.364 | nRot | 7 |
| Heavy Atom Molecular Weight | 308.204 | nRig | 14 |
| Exact Molecular Weight | 328.131 | nRing | 2 |
| Solubility: LogS | -3.686 | nHRing | 0 |
| Solubility: LogP | 3.53 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 49.0759 |
| nHD | 2 | BPOL | 24.4041 |
| QED | 0.463 |
| Synth | 2.074 |
| Natural Product Likeliness | 0.703 |
| NR-PPAR-gamma | 0.911 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.014 |
| Pgp-sub | 0.006 |
| HIA | 0.011 |
| CACO-2 | -4.821 |
| MDCK | 0.0000211 |
| BBB | 0.071 |
| PPB | 0.982867 |
| VDSS | 0.527 |
| FU | 0.0134752 |
| CYP1A2-inh | 0.966 |
| CYP1A2-sub | 0.705 |
| CYP2c19-inh | 0.96 |
| CYP2c19-sub | 0.099 |
| CYP2c9-inh | 0.91 |
| CYP2c9-sub | 0.96 |
| CYP2d6-inh | 0.906 |
| CYP2d6-sub | 0.907 |
| CYP3a4-inh | 0.796 |
| CYP3a4-sub | 0.496 |
| CL | 13.219 |
| T12 | 0.929 |
| hERG | 0.572 |
| Ames | 0.171 |
| ROA | 0.148 |
| SkinSen | 0.958 |
| Carcinogencity | 0.421 |
| EI | 0.572 |
| Respiratory | 0.262 |
| NR-Aromatase | 0.849 |
| Antiviral | Yes |
| Prediction | 0.529564 |